Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
97,733,829
-
Share change
-
+4,477,000
-
Total reported value
-
$1,887,229,460
-
Put/Call ratio
-
169%
-
Price per share
-
$19.29
-
Number of holders
-
199
-
Value change
-
+$89,016,125
-
Number of buys
-
103
-
Number of sells
-
101
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q1 2025
As of 31 Mar 2025,
Summit Therapeutics Inc. - COM (SMMT) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,733,829 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Pictet Asset Management Holding SA, Balyasny Asset Management L.P., and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This page lists
199
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.